Tuesday, May 17, 2011

Woodford Shale and Bakken Oil and Gas Stocks; (OTC.BB: AAPH), (NasdaqGS: BEXP), (NYSE: DVN), (NYSE: MRO), (NYSE: CLR)

Point Roberts WA - May 17, 2011 - www.Investorideas.com, an investor research portal specialized in sector research including oil and gas stocks, issues a sector close up on oil and gas shale stocks as the plays heat up. High oil prices have brought in more players into the shale stock plays. An estimated 160 oil and gas companies are now in the Bakken play.
  • American Petro-Hunter (OTCBB: AAPH) 52 Week range of $0.24 - 0.93
  • Brigham Exploration Company (NasdaqGS: BEXP ) 52 Week range of $13.45 - 37.87
  • Continental Resources (NYSE: CLR) Week range of $38.23 - 73.48
  • Devon Energy (NYSE: DVN) Week range of $58.58 - 93.56
  • Kodiak Oil & Gas Corp (AMEX: KOG ) Week range of $ 2.43 - 7.70
  • Marathon Oil (NYSE: MRO) Week range of $ 29.91 - 54.33
North American Bakken Oil Field Play - covering parts of Montana, North Dakota, and Saskatchewan.
The USGS estimate of 3.0 to 4.3 billion barrels of undiscovered, technically recoverable oil in the Bakken Formation, and a mean estimate of 3.65 billion barrels, is an estimate of what industry may recover if the entire area of prospective Bakken Formation is produced using current technology. The current USGS mean estimate is a 25-fold increase over the previous USGS estimate, in 1995, of 151 million barrels of undiscovered technically recoverable oil in the Bakken Formation. As of August 2009, cumulative oil production from the Bakken Formation totaled about 190 million barrels (up from 164 million barrels in March 2009, 149 million barrels in December 2008 and 135 million barrels in September 2008).
http://energy.cr.usgs.gov/oilgas/noga-
(choose Williston/Bakken in the interactive map to see all available documents).

Woodford Shale Emerging as a Leading Domestic Oil and Gas Play
Recent Commentary: Patrick J. Murphy, of Murphy Analytics LLC
Full article: http://www.investorideas.com/CO/AAPH/news/2011/03301.asp
As noted by American Petro-Hunter (OTCBB: AAPH) CEO Robert McIntosh in the Company's January 2011 Corporate Newsletter, production in the Woodford Shale has skyrocketed over the last few years. CEO McIntosh and others have referred to the Woodford as a world class oil and gas target, an assertion that seems justified given that the Woodford Shale now ranks second domestically in gas production and fifth in oil production. Following is data and commentary related to the operations and outlook for some of the Woodford Shale's most active players.
Devon Energy (NYSE: DVN): In a presentation1 at the Oppenheimer Unconventional Oil and Gas Conference, DVN noted that its Woodford assets benefit from a low cost of entry at approximately $2,200 per acre and a low average royalty burden at approximately 21%. The Company also notes that it recently completed construction of a gas processing plant, and after drilling 87 wells in 2010, DVN plans to drill over 200 wells in the Cana-Woodford Shale in 2011. Discussing the Company's Q4 20102 earnings, CFO and Executive Vice President Jeffrey Agosta commented on DVN's interest in the shale:
"Moving to the Cana-Woodford Shale in Western Oklahoma, we continue to add to our acreage position during the fourth quarter and now have approximately 243,000 net acres. Devon is currently operating 23 out of the 39 rigs running play-wide."
Marathon Oil (NYSE: MRO): At a recent Credit Suisse conference, MRO noted its interest3 in the Anadarko Woodford Shale play, with 3 rigs operating currently and 8 planned by the end of 2011. The company also observed that returns there are among the highest of domestic resource plays, and while exiting 2010 at approximately 1,500 BOED, MRO estimates that, by 2015, it could reach a peak rate of 30,000 BOED. In the Company's Q4 20104 conference call, Executive Vice President David Roberts noted that MRO plans to more than double its acreage in the area:
"Marathon also holds 86,000 acres in the Anadarko Woodford area, an area where we have operated for decades, and we have line in sight on new opportunity to increase that position to over 100,000 acres shortly. Importantly, we will have eight rigs in the play by 2011 by the end of this year."
Full article: http://www.investorideas.com/CO/AAPH/news/2011/03301.asp
More info: American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. www.americanpetrohunter.com
Company Research
http://www.aaphreport.com/
Visit the AAPH showcase profile at Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request News and Info on AAPH
http://www.investorideas.com/Resources/Newsletter.asp
Contact American Petro-Hunter:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including energy and mining stocks.
Research Energy Stocks at Investorideas.com
The energy stocks directory is available separately in a PDF of part of the Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water, mining, defense, biotech, nanotech and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Get Free stock alerts and news on energy stocks
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. American Petro-hunter Inc. (AAPH.OB) is a showcase energy stock on Investorideas.com and all related energy portals and blogs ( averaging two thousand per month) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
The author, Patrick Murphy, was compensated $350 for writing this article by InvestorIdeas.com. Mr. Murphy does not own shares of any of the companies mentioned in this article. Mr. Murphy expects his research firm, Murphy Analytics, to be engaged for the provision of a research report on AAPH in March 2011. Woodford Shale Emerging as a Leading Domestic Oil and Gas Play
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
Biotech/Pharma Stocks Alert; Hepatitis C Virus (HCV) FDA News from (OTCBB: AEMD), (NYSE: MRK), (VRTX)

Point Roberts, WA - May 17, 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector trading alert on Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc (VRTX)., Merck & Company, Inc.(NYSE: MRK) announcing FDA updates on Hepatitis C Virus (HCV) treatments.Merck (NYSE: MRK) announced Friday that the U.S. Food and Drug Administration (FDA) had approved VICTRELIS™ (boceprevir), for the treatment of chronic hepatitis C (CHC).
First to market with a treatment for the virus that infects approximately 3.2 million Americans a year, Merck.(NYSE: MRK ), has Vertex Pharmaceuticals Inc (VRTX ) following right behind it with INCIVEK (in-SEE-veck) the trade name for telaprevir. Aethlon Medical, Inc. (OTCBB: AEMD) is taking a different approach, using technology as a potential treatment.
Aethlon Medical, Inc. (OTCBB: AEMD) recently announces it submitted a request to the U.S. Food and Drug Administration (FDA) for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier® in the United States.
Trading Snapshot (As of close of trading May16th)
  • Aethlon Medical, Inc. (OTCBB: AEMD) closed at $0.12, up 0.02 (20.00%)
  • Merck & Company, Inc. (NYSE: MRK ) closed at $37.30, up 0.22 (0.59%) on over 18 Million shares
  • Vertex Pharmaceuticals Inc (VRTX ) closed at $57.27, down 0.21 (0.37%) but was up in after hours trading.
Market Snapshot (As of close of trading May16th)
  • Dow 12,548.37 -47.38 -0.38%
  • NASDAQ 2,782.31 -46.16 -1.63%
  • S&P 500 1,329.47 -8.30 -0.62%
  • 10 Yr Bond (%) 3.1490% -0.0380
  • Oil 97.07 -2.58 -2.59%
  • Gold 1,490.70 -2.70 -0.18%
Hepatitis C Virus (HCV) News:
FDA Approves Merck's VICTRELIS™ (boceprevir), First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor
WHITEHOUSE STATION, N.J., May 13, 2011 - Merck (NYSE: MRK ) (known as MSD outside the United States and Canada) announced today that the U.S. Food and Drug Administration (FDA) has approved VICTRELIS™ (boceprevir), the company's innovative new medicine for the treatment of chronic hepatitis C (CHC). VICTRELIS is approved for the treatment of CHC genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients (18 years of age and older) with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.
Full news:http://www.merck.com/newsroom/news-release-archive/prescription-medicine-news/2011_0513.html?WT.svl=content&WT.pi=content+Views
Aethlon Medical, Inc. (OTCBB: AEMD) recently announces that it has submitted a request to the U.S. Food and Drug Administration (FDA) for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier® in the United States. As part of these discussions, Aethlon management will present FDA officials with new clinical data that supports the safety of the Hemopurifier® and demonstrates the capability of the medical device to reduce viral load in individuals infected with the hepatitis C virus (HCV). Based on the data to be presented, Aethlon will request permission to expand the target treatment indications of the Hemopurifier® to include HCV in the U.S. At present, the treatment indication underlying the Aethlon IDE is solely directed toward the use of the Hemopurifier® as a countermeasure against bioterror and pandemic threats.
Full News: http://www.investorideas.com/CO/AEMD/news/2011/05091.asp
Vertex Pharmaceuticals Inc (VRTX ) reported in its May 3 rd update that they intend to use the name INCIVEK (in-SEE-veck) as the trade name for telaprevir. If approved, telaprevir will be marketed by Vertex as INCIVEK in the U.S. Vertex recently completed its FDA Antiviral Drugs Advisory Committee meeting for INCIVEK (telaprevir). At the conclusion of the meeting, the committee voted unanimously (18-0) to recommend FDA approval of INCIVEK (telaprevir) for people with genotype 1 chronic hepatitis C who were not treated previously and those who were treated previously but not cured with currently available medicines. Vertex expects the FDA to provide its formal decision on the New Drug Application for INCIVEK (telaprevir) by May 23.
Full news: http://finance.yahoo.com/news/Vertex-Reports-First-Quarter-bw-1531348977.html?x=0&.v=1
Company Snapshot
About Aethlon Medical (OTCBB: AEMD)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get added to the company's news alerts:
http://www.investorideas.com/Resources/Newsletter.asp
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Contact:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011       
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011

Monday, May 16, 2011

Oklahoma Energy Stocks Trading Alert; (OTCBB: AAPH), (NYSE: DVN), (NYSE: XEC), (NYSE: CLR)


Point Roberts, WA - May 16 , 2011 (Investorideas.com Energy Newswire) - www.InvestorIdeas.com, a leader in sector research including energy stocks releases a trading alert for oil and gas stocks drilling in Oklahoma including American Petro-hunter Inc (OTCBB: AAPH), Devon Energy Corporation (NYSE: DVN),Cimarex Energy (NYSE: XEC) and Continental Resources, Inc. ( NYSE: CLR).
Devon Energy Corporation (NYSE: DVN )recently reported first-quarter production benefited from better than expected results from several core properties, including the Cana-Woodford and Barnett Shale.
American Petro-Hunter, Inc. (OTC.BB: AAPH) announced today that drilling operations have commenced at the Company's newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company's first horizontal well, designated NOM1H.
According to research at http://www.aaphreport.com/,”American Petro-hunter Inc (OTCBB: AAPH) is the only junior oil and Gas Company taking part in the play in the heart of the excitement taking place right now in Payne County, Oklahoma! “
Sector Snapshot
  • American Petro-hunter Inc (OTCBB: AAPH) trading at $0.39, up 0.0010 (0.26%)
  • Devon Energy Corporation (NYSE: DVN ) trading at $82.58, up 0.56 (0.68%) 12:12PM EDT
  • Cimarex Energy (NYSE: XEC ) trading at $92.90, up 0.28 (0.30%)
  • Continental Resources, Inc. (NYSE: CLR ) trading at $60.09, down 0.71 (1.20%) 12:20PM EDT
Market Snapshot
  • Dow 12,618.34 +22.59 +0.18%
  • Nasdaq 2,809.28 -19.19 -0.68%
  • S&P 500 1,338.41 +0.64 +0.05%
  • 10 Yr Bond(%) 3.1670% -0.02
  • Oil 98.17 -1.48 -1.49%
  • Gold 1,489.70 -3.70 -0.25%
Recent Oklahoma Oil and Gas Stocks News;
Devon Energy Earns $416 Million in First-Quarter 2011; North American Onshore Production Increases 7 Percent
OKLAHOMA CITY---- Devon Energy Corporation (NYSE:DVN - News) today reported net earnings of $416 million for the quarter ended March 31, 2011, or $0.97 per common share ($0.97 per diluted common share). This compares with first-quarter 2010 net earnings of $1.2 billion, or $2.67 per common share ($2.66 per diluted common share). The decrease in quarterly earnings is primarily attributable to non-cash, unrealized changes in the fair value of oil, gas and NGL derivatives.
First-quarter 2011 financial results were impacted by certain items securities analysts typically exclude from their published estimates. The most significant of the adjusting items was a non-cash, unrealized loss on oil, gas and NGL derivatives of $254 million before-tax ($166 million after-tax). Excluding these adjusting items, Devon earned $575 million or $1.34 per diluted common share in the first quarter of 2011. The adjusting items are discussed in more detail later in this news release.
Production Growth Exceeds Guidance, Driven By Strong Liquids Growth
Production from continuing operations averaged 629,000 oil-equivalent barrels (Boe) per day in the first quarter of 2011, in spite of curtailments related to severe winter weather. Compared to the first quarter of 2010, Devon’s North American onshore production increased seven percent and exceeded the top-end of the company’s guidance by 4,000 barrels per day. First-quarter production benefited from better than expected results from several core properties, including the Cana-Woodford and Barnett Shale.
American Petro-Hunter (OTCBB: AAPH) Announces Drilling of Horizontal Well at North Oklahoma Project
SCOTTSDALE, AZ - May 16, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB: AAPH) ("American Petro-Hunter" or the "Company") is very pleased to announce that drilling operations have commenced at the Company's newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company's first horizontal well, designated NOM1H.
Full news: http://www.investorideas.com/CO/AAPH/news/2011/05161.asp

About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
American Petro-hunter Inc (OTCBB: AAPH) is a showcase Oil and Gas stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AAPH/ 
Equity research report on American Petro-Hunter Inc (OTCBB: AAPH
Read the report at www.grassrootsrd.com and http://www.investorideas.com/CO/AAPH/Cohen_AAPH_report_100510.pdf
Request info on AAPH:
http://www.investorideas.com/Resources/Newsletter.asp
About Investor Ideas Oil and Gas portal: OilandGasStocksNews.com is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Investorideas.com features third party research in multiple industry sectors including energy, biotech and mining.  More third party research reports can be found at http://www.investorideas.com/Research/.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (averages 2000 per month. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Solar Stocks and Market Commentary with J Peter Lynch

Point Roberts, South Salem, New York – May 16, 2011 www.Investorideas.com, a leader in cleantech stock research, releases a new solar stocks review from contributor, J. Peter Lynch for May 16th.
Solar Stocks Commentary with J Peter Lynch -

Read other articles, Exclusively for InvestorIdeas.com and Renewableenergystocks.com: http://www.renewableenergystocks.com/PL/

See Peter's technical solar stocks review: http://www.investorideas.com/PL/Solar-Stocks-Review.asp

Solar Stocks Review - Monday 3-21-2011
J Peter Lynch
Summary
At this time the general market continues to stay in a higher risk zone. This does not mean that you cannot make money but that most of the money has usually been made at this stage. However, it is not uncommon for the market to stay in a higher risk zone for many months.
As a result, an investor has to be more cautious and take some more defensive actions. For example, sell stocks in your portfolio that are showing weakening relative strength to the market, tighten up your stop loss sell points and if you are more sophisticated, buy protective puts to hedge yourself.
However, the market has been climbing a "wall of worry" for a long time now, volatility has dramatically increased and the market has moved into its traditionally unfavorable season - May thru September approximately - additional reasons for caution.
Remember the two key rules from the legendary investor Warren Buffet on how to make money in the stock market:
  1. Never lose money*
  2. Never forget rule #1
*What Buffet really means by "never lose money" is really to cut your losses short (minimize your losses) and let your winners run as long as they are technically strong (maximize your return).
Individual Stock Comments and Comments on our Solar Portfolio
Most of the stock s in the solar sector have fallen further behind the general market and have continued to weaken. Below are the latest comments on the 3 stocks remaining in our Solar Portfolio and the number of shares of each stock still held in the portfolio.
To date the portfolio is up approximately double the major industry averages 15% vs 7.25%.
JKS (500 shares) - Stock has recently showed strength and has given a new short term buy signal at $28.50. Falling below $25.50 would generate at sell signal for the remaining ½ of the position.
SOLR (1,000 shares) - Consistently the strongest solar stock and has given a short term buy signal at $11.50, it is the only stock in the portfolio that we have not sold any of our initial position of 1,000 shares.
TSL (500 shares) - weakest of the group, a move to $25.50 generated a sell of ½ of our position. A further move down to $25.00 would generate a sell signal on the balance of this position.
Looking at the table below you will see that both JKS and SOLR are the only major stocks that are significantly above both their 50 Day and 200 day moving averages**. With the exception of Sunpower Corp. (SPWRA) which received a recent offer for control of the company by the French oil company TOTAL.
**Remember that the 50 day MA is a short term indicator of technical strength and the 200 day MA is a long term indicator of strength. The optimal position for a stock to be in is ABOVE both these moving averages.
US Photovoltaic Related Companies as of the close on 5-13-2011
SymbolNameRecent Price50 Day MA200 Day MA
ASTIAscent Solar Technologies, Inc.1.562.1073.059
CSIQCanadian Solar Inc.9.6810.80213.017
CSUNChina Sunergy Company Ltd.3.33.8734.276
DSTIDayStar Technologies Inc.0.790.891.523
EMKREMCORE Corporation2.482.4281.584
ENEREnergy Conversion Devices1.572.23.988
ESLREvergreen Solar, Inc.1.081.5353.322
FSLRFirst Solar, Inc.125.65143.077140.584
HSOLHanwa Solar5.917.0539.175
JASOJA Solar Holdings Co., Ltd6.166.5797.237
JKSJinkoSolar Holding Co.28.525.37726.161
LDKLDK Solar Company Ltd.9.611.32410.77
RSOLReal Goods Solar, Inc.2.532.5092.731
SOLReneSola, Ltd.8.259.1269.973
SOLRGT Solar International Inc11.3610.4419.288
SPIRSpire Corporation4.284.3664.848
SPWRASunpower Corporation21.2317.29514.483
STPSuntech Power Holdings8.528.9268.827
TSLTrina Solar Limited25.3527.53426.37
WESTAkeena Solar, Inc.1.521.9292.187
WFRMEMC Electronic Materials, Inc.11.0112.05411.912
YGEYingli Green Energy10.6611.79111.523
Background Notes
Keep in mind that there are two basic types of equity (stock) analysis. Below is a brief description of each and its primary purpose:
Fundamental Analysis - this is the analysis of the fundamental financial condition of the company to identify which stocks are stocks you may want to buy when the timing is right. This form of analysis will give you NO indication of the best time to buy the stock.
Technical Analysis - this form of analysis will tell you "when" to buy a stock. It will do this by showing you (in chart format) the basic interaction of supply and demand and when the two change and shift which will indicate a time to buy or a time to sell.
Mr. Lynch has worked, for 34 years as a Wall Street security analyst, an independent security analyst an investment banker and private investor in small emerging technology companies. He has been actively involved in following developments in the renewable energy sector since 1977 and is regarded as an expert in this field. He was the contributing editor for 17 years to the Photovoltaic Insider Report, the leading publication in PV that was directed at industrial subscribers, such as major energy companies, utilities and governments around the world. He is currently a private investor and advisor to a number of companies. He can be reached via e-mail at: SOLARJPL@aol.com. Please visit his website for the promotion of solar energy - www.sunseries.net
Subscribe to the Peter Lynch solar RSS feed; http://www.investorideas.com/RSS/feeds/PL.xml
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com® or any of the industry sector portals. At the time of publication, writers may hold positions in the stocks or companies mentioned.
Research other solar with the renewable energy stocks directory ; a global stock directory featuring over 1100 green stocks. Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
Get free investor stock alerts and newsletters:
http://www.investorideas.com/Resources/Newsletter.asp

About Investorideas.com Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information contact Investor Ideas:
Dawn Van Zant 800.665.0411, Email: dvanzant@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.RenewableEnergyStocks.com, www.Investorideas.com
Cloud Computing Stock News; IBM and GROUP Business Software AG (OTCBB:GBSX) Sign Cloud Computing Joint Cooperation Agreement

NEW YORK - May 16, 2011 (Investorideas.com cloud computing stocks newswire) � GBS Enterprises Incorporated's (OTCBB:GBSX) subsidiary, GROUP Business Software AG (GBS), signed a joint cooperation agreement with IBM (NYSE:IBM) to provide cloud computing to their enterprise clients in Germany. GBS Enterprises Incorporated owns 50.1% equity interest in GROUP Business Software AG.
The below press release was previously announced by IBM in Germany on April 29, 2011.
April 29, 2011 -- Frankfurt, Germany -- IBM and GROUP Business Software AG (GBS) announced the further expansion of their existing cooperation in the field of cloud computing. The two companies have signed a joint cooperation agreement to address the rapidly expanding market demand for Cloud-Technology solutions in Germany. The primary goal is to better respond to the growing and evolving customer requirements for automated application delivery in clouds and to better manage the complexity of new technologies in heterogeneous environments.
GBS is providing the technology basis with its GROUP Live PaaS cloud platform, while IBM is contributing system integration services, project management and data center operations, in this comprehensive partnership. GROUP Live allows companies to cloud-enable their solutions and to deliver them quickly and fully automated as SaaS applications, significantly improving cost-effectiveness in the deployment and use of these applications.
The two companies will position the resulting solution portfolio with the initial focus on small and medium-sized enterprises while working closely together in the fields of sales, technical services and marketing.
"After we have successfully positioned our cloud platform in the market and already received strong recognition from IBM through a number of awards, we are now looking forward to taking the next step in our relationship", said Constanze Zarth, COO Europe at GBS. "This cooperation at a strategic level is an important milestone for us to open up new ways in the delivery of applications with our joint cloud offering".
"With GBS, we have a long-standing IBM Premium Partner on our side, whose cloud technologies will be of great benefit to customers in the Software-as-a-Service market", says Frank Strecker, Director Cloud Computing, IBM Germany. "At the same time, they will be able to draw on IBM's expertise and secure infrastructure for solutions in the cloud."
About GBS Enterprises, Inc.
GBS Enterprises Incorporated (OTCBB:GBSX) is the 50.1% parent company of Group Business Software AG which is focused on Cloud Computing solutions primarily for the IBM Lotus market. GBS has more than 4,000 customers worldwide with more than 4 million users of their products and services; and has offices in New York, Boston, Atlanta, Toronto, London, Manchester, Copenhagen, and throughout Germany. Its European headquarters is in Frankfurt, Germany and North American headquarters is located in New York City. For more information, please visit www.gbs.com. The contents of the Company's website are not incorporated by reference into this Press Release.
Caution Concerning Forward-Looking Statements
This release contains statements, which may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or expectations of the Company. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that results may differ materially from such statements.
Contact:
GROUP Business Software AG:
Marketing and Communications Contact:
Michael Baum, Corporate Communications,
michael.baum@us.gbs.com
GBS Enterprises Incorporated:
Investor Relations Contact:
Gary MacDonald, EVP and Chief Corporate Development Officer,
gmacdonald@gbsx.us
Disclosure: GBS Enterprises, Inc. (OTCBB:GBSX) is a paid showcase tech stock, cloud computing stock on Investorideas.com (April 2011 - 1500 per month by third party)
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Biotech and Pharma Stocks Research News; Q1 Publishing Research Report on Verisante Technology, Inc. (TSX-V: VRS) (OTC: VRSEF)


May 16, 2011 - Investorideas.com newswire, a leader in investor stock research including biotech stocks, publishes the following Q1 Publishing Research Report on Verisante Technology, Inc. ( TSX-V: VRS) (PINK SHEETS: VRSEF). Q1 Publishing is an independent investment research firm which offers research on effective investment tools to investors. (http://www.q1publishing.com/investmenttools/reports)
Investorideas.com Newswire features third party research and equity reports from multiple research firms from within the investment community.
Jump on this Rapidly Unfolding Med-Tech Innovation Now
By Andrew Mickey, Q1 Publishing
We've only had this feeling a few times before.
It's the feeling we're onto something big - real big - at a very early state.
The same feeling we had about fertilizer stocks in July 2006. The same feeling about the Nintendo Wii when it exploded in Japan and its US launch was still months away. Or when Intuitive Surgical's robotic surgery technology was just making it into hospitals.
You know the feeling you're sitting on your next five- or 10-bagger, you understand it, you know it's big, and you're just waiting for everyone else to figure it out.
Frankly, it's a rare feeling. It's even rarer in a market like this where everything seems priced for perfection.
It's rare, but it's not impossible. Right now, we've got that feeling one small and fast-growing company is about to change a lucrative medical field for the better. And do it soon.
But we're not alone here. Some of the leading medical journals and magazines see the enormous potential we've spotted.
Biotechnology Focus magazine calls this development "ingenious."
The BC Medical Journal says, "Preliminary clinical results have so far demonstrated 100% efficacy."
Darrell Rigel, a professor of dermatology at NYU's Langone Medical Center, told MIT's Technology Review journal there's "a need" for innovations like this.
Despite the medical community's excitement, it still hasn't gone mainstream…yet.
Our window of opportunity to buy into Verisante Technology (TSX-V: VRS or OTCQX: VRSEF) will not be open forever.
Right now Verisante is a small $35 million company, just on the verge of leading medical technology revolution, has shown stellar preliminary clinical results, and based on market comparables is a ten-bagger-in-waiting.
In a few months, all that will be history and Verisante will be value much higher. Let's start at the beginning.
The Next Big Med-Tech Winner
If you're like me, you've learned (the hard and often expensive way) to become highly skeptical when it comes to new technologies.
They consistently over promise and under deliver.
Well, I think Verisante has under promised and is set to over deliver.
Verisante is aquickly emerging medical technology (med-tech) company which, despite its small size, is on the verge of doing something truly revolutionary.
The technology has been in development for 10 years. Its development has been led by some of the world's leading cancer researchers. It has received funding from leading cancer research organizations including the BC Cancer Society.
And, although it's technology has the potential to change almost every field of medicine, it's initially focused on a subsector of the medical field that's overdue for innovation.
Now with a recent $5 million capital infusion to take it to final commercialization, Verisante is poised to make it very big, very soon.
10 Years of Development About to Pay Off
Verisante is has entered the final approval stages for its proprietary cancer screening device.
On the surface, Verisante's Aura device is really simple. It detects cancerous cells by an advanced laser scanning system. And it does it with an astonishing rate of accuracy.
Think of a price scanner at the grocery store. It scans a bar code and tells you the price. Verisante's Aura concern detection device scans a skin lesion and tells you if it's cancerous. (For a complete explanation of how it works, follow this link to a recent feature on Canada's BTV )
Again, it really is a simple concept. But the science behind it is much more advanced than that.
Most importantly though, the Aura has shown the potential to revolutionize cancer detection and save a lot of lives and money in the process.
Verisante has targeted melanoma, one of the most feared and costly to treat cancers, for its initial launch.
Future Market Domination
The Aura device has shown remarkable accuracy and consistency in detecting melanoma at a very early stage (more details below).
Skin cancer is one of the most common forms of cancer. More than two million Americans are diagnosed with it each year. It will affect one in five US residents. And at least 40% of Americans can expect to get non-melanoma skin cancer before they turn 65.
Melanoma specifically one of the most deadly types of cancer. If detected in the Stage I it has an 85% survival rate. In Stage IV the survival rate falls to an ominous 15%.
Melanoma and skin cancer is costly too. It costs $1.5 billion a year to treat melanoma alone.
Despite the high costs of treatment and its deadly nature, there has been little advancement in detection.
For decades, dermatologists have relied on their eyes and patients to self-identify abnormal growth in moles and skin lesions. These crude methods successfully identify about one in three cases of melanoma.
Recently, however, the markets had high expectations that one of Verisante's competitors made a major breakthrough in melanoma detection. And investors were willing to pay top dollar merely speculating the technology worked effectively and consistently enough for regulatory approval.
Why Verisante is a True 10-Bagger
Knowing differences between the Verisante's and MELA Sciences (NASDAQ:MELA) – Verisante's closes competitor - devices reveals the true opportunity here.
MELA has been one of the most closely watched med-tech device stocks over the last year.
MELA's melanoma detection device, MelaFind, was in the final stages of regulatory approval heading into the end of 2010.
Investors were willing to risk getting in early because the upside potential was massive. If approved, MELA would be dominating a mult-billion dollar market virtually overnight.
MELA shares ran to more than $9 per share in anticipation of U.S. Food and Drug Administration (FDA) approval. At its peak, the total market value exceeded $200 million. Keep in mind, MelaFind is only aimed at melanoma and not the many other cancers Verisante's Aura has the potential to be used to detect. And it still was worth $200 million.
Then last November the FDA rejected MELA's device and its shares plummeted.
But here's the thing, MELA's device was rejected for a number of reasons that Verisante will not be affected by.
MELA was rejected because of its low degree of accuracy and large number of false positives.
In my opinion, MelaFind was basically not much more effective than what a dermatologist can determine just by looking at a suspicious mole.
The FDA requires a device to have a certain level of accuracy and consistency. MelaFind had neither.
Now MELA is going to need more studies and more capital to complete those studies. Yet it still has a market value almost three times higher than Verisante.
Key to Success: The Molecular Signature
The key difference between MELA's device and Verisante's is how they identify potentially cancerous cells.
MelaFind takes a picture of a mole or lesion. It then analyzes it against a database of images of confirmed melanoma cases. It uses a proprietary algorithm to compare shapes, sizes, and abnormalities of the lesions. This method didn't produce the accuracy or consistency required by the FDA.
Verisante's device works in a completely different way.
The Aura device analyzes what I call the "molecular signature" of the mole or lesion to determine whether it's likely cancerous or not.
The Aura uses Raman spectroscopy to detect the potential cancer at the molecular level. The studies conducted on the Aura device confirm how effective this process is.
In a six-year clinical trial conducted at the University of British Columbia's dermatology department and Vancouver General Hospital (which has 80,000 dermatoligical patients per year), the Aura device has detected melanoma with incredible accuracy and consistency.
Over a preliminary sample of 274 lesions, the Aura identified 45 melanoma occurrences. Thirty four of those occurrences identified by Aura were confirmed by a biopsy.
These preliminary results give melanoma a 100% accuracy rate and, as a testament to the reliability of the device, a 70% specificity.
These rates are critical part of the regulatory review process. The accuracy rate shows Aura works. The specificity rate shows Aura doesn't give too many "false positive" diagnoses. After all, you can't have a device that gives too many false positives. It would be worthless if it did.
This kind of accuracy and specificity is the critical difference for Verisante. And it shows how revolutionary this product is.
But it takes more than a better mousetrap to be successful. And Verisante has laid out a business model that has been exceptionally profitable for many of the leading companies in the world.
A Dermatologist's Perspective
The most impressive part of Verisante is its business model for commercializing the Aura device.
Once the Aura is approved, Verisante has planned a way to generate a profit by both selling its Aura devices and still earning an ongoing stream of revenue.
Verisante is using the "razor and blade model."
Do you think Gillette makes a lot of money selling a Mach 3 razor for $12? They do, but they make a lot more selling $4 razors month after month after month. Verisante is using the same strategy.
Let's take it from a dermatologist's perspective.
A skin doctor would be able to buy an Aura device and generate a lot of revenue from it. They would be able to charge anywhere from $100 to $500 for a cancer screening and do it for thousands of patients each year.
Many, I'm sure, would be able to pay at least $50,000 for a device that could generate between $100,000 to $1 million a year in revenue from it.
Verisante will likely be able to be able to build Aura devices for about $10,000. This will likely improve as demand increases and economies of scale are achieved, but let's take the more conservative $10,000 estimate. Verisante would be able to sell the device for between $30,000 and $60,000 to dermatologists.
That's a solid margin. The real money, however, comes from the continuous revenue it would receive. The "blades" part of the razor and blade model.
Each screening with the Aura device requires a new tip. The tip includes a lens and other proprietary features to prevent misdiagnosis. Verisante sells the specialized tips required for each use. The tips would likely cost dermatologists $10 each and significantly less to produce.
Verisante would be generating between $20,000 and $50,000 in gross profit per sale of each device. Then it would generate anywhere from $10,000 to $100,000 in additional revenues from the specialized tips from each device owner per year, every year.
Multiply those numbers out over a few hundred dermatologists (although there are thousands around the world) and you get some staggering numbers.
It's a massive opportunity which has the potential to make Verisante a $1 billion company as the Aura spreads across high-demand markets in Canada, Europe, and the United States.
On top of that, it's important to keep in mind that's just with melanoma. Verisante's technology has been proven to successfully identify many different types of cancers. Early trials have shown its effectiveness in identifying lung, cervical, and colon cancer.
Melanoma is just where Verisante's technology has had most of the research and testing geared towards. Once you add in potential opportunities in the other cancers, Verisante's potential is exponentially higher over the long run.
Nearing the Finish Line
Verisante seems to have it all. It's better, cheaper, and potentially very profitable. But the key with any investment in medical technology is completing the regulatory approval processes.
Verisante is aiming at completing the regularity approval process in a faster, less-costly way.
First, most of the expensive and time-consuming research is already completed. The Aura device has been in development for about 10 years. And it already has one six-year study completed.
Now Verisante is in the final stages of approval with Canadian medical authorities. Final approval is expected to be made by the end of 2011.
After that, Verisante has already started the European approval process. It expects to the "CE Mark" (the symbol of European approval) to be granted as early as the end of 2011.
If and when this is approved, Verisante has instant access to markets in the European Union, South Africa, and Australia.
Finally, with European and Canadian approval in hand, its' going to then move to the United States. It needs more studies for U.S. approval, but like many other drugs and medical devices, it's a lot more likely to get approval in the United States after Canada and Europe give the official thumbs up.
A Big Winner in the Making
Verisante Technology (TSX-V:VRS or OTCQX:VRSEF) is in position to have an exciting few months ahead as the story unfolds and even more great years beyond that.
It has all the elements of a giant med-tech success story.
It has superior, proven technology.
It has years of costly and time-consuming research behind it.
It's very near to final regulatory approval in Canada.
It has shown the potential to save a lot of lives too.
On top of all that, Verisante was recently able to attract an addition $5 million capital infusion in a market where med-tech and biotech aren't getting very much venture capital.
Perhaps most importantly, Verisante has huge growth potential. At a mere $35 market cap, the upside is tremendous. Remember, its closest competitor, MELAScience, had a market value of about $200 million just in anticipation it would be successful. And after it got rejected by the FDA, it still has a $90 million market value.
That's the kind of potential here where once the Aura is approved; Verisante is on its way to being worth $1 billion.
Head over to Verisante.com to see for yourself.
Andrew Mickey
Chief Investment Strategist, Q1 Publishing
Disclosure: The editor does not own shares and is not paid by any of the companies mentioned for distribution of this report. It is, however, an open recommendation in Q1 Publishing's President's List premium research service.
If you like ideas and research like this, the President's List is a premium investment research focused on the maximum risk-reward opportunities available anywhere in the world. You can learn more about a no-risk trial offer here. Legal Disclaimer : The information contained on this e-mail and in other Q1 Publishing communications is intended for general information purposes only. Q1 Publishing has not taken into account the specific investment objectives of any particular investor. You should always seek the counsel of a professional financial advisor before purchasing or selling stock. Directors, employees and outside contributors to Q1 Publishing may hold substantial positions in the recommended securities and may increase or decrease such positions without notice. We believe the sources of information to be reliable but Q1 Publishing does not guarantee the accuracy or completeness of the information provided on this website or in other Q1 communications, and expressly disclaims liability for any errors or omissions that may be contained in the information
More research;
To view a profile on Verisante Technology, Inc. ( TSX-V: VRS ) (PINK SHEETS: VRSEF) as aired on BTV, click on the following link
http://www.youtube.com/verisante#p/u/2/PHugTxLXQGI

To view the Zacks Investment Research Initiation Report on Verisante Technology, Inc. ( TSX-V: VRS ) (PINK SHEETS: VRSEF) click on the following link:
http://verisante.com/docs/verisante_zacks.pdf

To view media articles and stories on Verisante Technology, Inc. ( TSX-V: VRS ) (PINK SHEETS: VRSEF) click on the following link:
http://verisante.com/news/media/
Investorideas.com disclaimer and disclosure � the following news is a paid news release distribution (one thousand for 2 releases) Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
The published report by Q1 Publishing is the property of Q1 Publishing and is not the opinion of Investorideas.com. Investorideas.com is a news publisher of third party research.
Oil and Gas Stocks News; American Petro-Hunter (OTCBB: AAPH) Announces Drilling of Horizontal Well at North Oklahoma Project

SCOTTSDALE, AZ � May 16, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is very pleased to announce that drilling operations have commenced at the Company's newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company's first horizontal well, designated NOM1H.
NOM1H is scheduled to spud tomorrow and is the first of an anticipated series of horizontal wells designed to exploit the Mississippi Formation. The over 100-foot thick limestone is the central focus of the well documented recent drilling and leasing frenzy in Oklahoma. Hundreds of horizontal wells have been executed, planned and/or implemented by companies such as Sandridge and Calyx in recent months. Of particular note, Sandridge announced in its latest year end filing that it had drilled and completed 29 wells with 8 remaining to be completed in the area.
The NOM1H well is anticipated to take several weeks to reach its engineered total depth, following which it will undergo a period of testing and evaluation. With the high success rate of analog wells in the area American Petro-Hunter has great hopes for a successful producer in this highly sought after oil play.
As the activity in the area has become extremely competitive, and information regarding detailed production rates of commercial quantities of oil and natural gas is increasingly regarded as tightly held information, the Company will endeavor to update stakeholders on a timely basis with drilling results as such information becomes available from the operator.
Company President Robert McIntosh states, "We are extremely pleased to have begun our very first venture into the realm of horizontal well drilling. This venture offers us a possibility like no other, to immediately and significantly increase our oil production. The opportunity to be right in the heart of the hunt for 'big oil' in Oklahoma is an exciting step for the Company and we hope will prove to be beneficial for all concerned."
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
Oil and Gas News; American Petro-Hunter (OTCBB: AAPH) Announces Drilling of Horizontal Well at North Oklahoma Project



SCOTTSDALE, AZ -- -- May 16, 2011 – American Petro-Hunter, Inc. (OTCBB: AAPH) (“American Petro-Hunter” or the “Company”) is very pleased to announce that drilling operations have commenced at the Company’s newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company’s first horizontal well, designated NOM1H.

NOM1H is scheduled to spud tomorrow and is the first of an anticipated series of horizontal wells designed to exploit the Mississippi Formation. The over 100 foot thick limestone is the central focus of the well documented recent drilling and leasing frenzy in Oklahoma. Hundreds of horizontal wells have been executed, planned and/or implemented by companies such as Sandridge and Calyx in recent months. Of particular note, Sandridge announced in its latest year end filing that it had drilled and completed 29 wells with 8 remaining to be completed in the area.



The NOM1H well is anticipated to take several weeks to reach its engineered total depth, following which it will undergo a period of testing and evaluation. With the high success rate of analog wells in the area American Petro-Hunter has great hopes for a successful producer in this highly sought after oil play.



As the activity in the area has become extremely competitive, and information regarding detailed production rates of commercial quantities of oil and natural gas is increasingly regarded as tightly held information, the Company will endeavor to update stakeholders on a timely basis with drilling results as such information becomes available from the operator.



Company President Robert McIntosh states “We are extremely pleased to have begun our very first venture into the realm of horizontal well drilling. This venture offers us a possibility like no other, to immediately and significantly increase our oil production. The opportunity to be right in the heart of the hunt for “big oil” in Oklahoma is an exciting step for the Company and we hope will prove to be beneficial for all concerned.”



About American Petro-Hunter, Inc. (OTCBB: AAPH)

The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas and the North Oklahoma Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the “hunt” for domestic petroleum assets. Visit us at: www.americanpetrohunter.com



Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.



ON BEHALF OF THE BOARD

American Petro-Hunter, Inc.

- - - - - - - - - - - - - - - - - -

Robert McIntosh

President & C.E.O.



To find out more about American Petro-Hunter, Inc. (OTCBB: AAPH), visit our website at www.americanpetrohunter.com



Investor Relations:

Mountainview IR Services, Inc.

1-888-521-7762

investors@americanpetrohunterinc.com



American Petro-hunter Inc (OTCBB: AAPH) is a showcase Oil and Gas stock on Investorideas.com (please read disclosure and disclaimers)



Visit the showcase page on Investorideas.com

http://www.investorideas.com/CO/AAPH/



Request info:

http://www.investorideas.com/Resources/Newsletter.asp



About Investor Ideas Oil and Gas portal: OilandGasStocksNews.com is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily

to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.

Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (averages $ 2000 per month ). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investing involves risk and possible loss of full investment .

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp

Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

The research report mentioned in this article is the content and opinion of Grass Roots Research and Distribution, Inc., not Investorideas.com or its related sites.

Sunday, May 15, 2011

Gold and Mining Stocks Investors- become a Facebook.com Fan and receive free mining stocks directory

Investorideas.com invites investors trading gold and mining stocks to become a Facebook.com Fan and receive free mining stocks directory
Investors can also Register for free online mining conference, Follow the Money in Mining and Metals - Learn how to trade mining and gold stocks
http://www.investorideas.com/, a global investor research portal, specializing in sector research, including mining and gold stocks invites investors to join us on Facebook.com and get a free mining stocks directory, with over 1300 listed gold and mining stocks ($29.95 value) . The directories are part of the comprehensive investor research tools Investorideas.com offers to independent investors.

The stock directories are just one of the tools to help investors in the mining sector. This month, Investorideas.com and Smallcapvoice.com are hosting the online mining conference, Follow the Money in Mining and Metals, May 25th and 26. The online conference is free to investors with login registration.

Free Investor Sign-Up - http://www.smallcapvoice.com/ii_scv/investor-signup.html


Facebook Badge

Look for us on Facebook.com -

Investorideas.com- Investing ideas that can change the world

http://www.facebook.com/pages/Investorideascom-Investing-ideas-that-can-change-the-world/188472654518401


FACEBOOK BADGE

Investorideas.com- Investing ideas that can change the world

About our mining stocks directory:

Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1300 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.

Email us at dawn@investorideas.com and let us know you have become a fan and we will email you the PDF free!

More mining stocks research - free online investor conference

Follow the Money in Mining and Metals, May 25th and 26.

The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.

The event will be pre-recorded and go live May 25th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.

Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp


Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html

Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html


About our Mining Portals:
http://www.gold-miningstocks.com/ and http://www.miningsectorstocks.com/ are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1300 mining stocks.

Become an Investor Ideas Member - Get  even more stock research !

Investor Ideas members get access to the most comprehensive stock directories online with 24/7 login access to water stocks, renewable energy stocks and more. Learn more: http://www.investorideas.com/membership/


Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com

Offer limited to first 25 new fans

Friday, May 13, 2011

Mining and Gold Stock News; Goldcorp (TSX: G, NYSE: GG), (TSX.V: CUI) (OTC: CUIRF), (TSXV: UVR), (TSX-V: YLL and Frankfurt: YAB) (TSX-V: RUN) (US OTC: RFXRF) (FRANKFURT: C8Q), (TSX-V: TRM) at Mining and Metals


May 13, 2011 - www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor stock announce publicly trading mining stocks and presenters at this month’s free online investor conference discussing the future of mining stocks. Presenting Mining Stocks Include; (TSX: G, NYSE: GG), (TSX.V: CUI), (TSXV: UVR), (TSX-V: YLL), (TSX-V: RUN) and (TSX-V: TRM).
Mining company, Goldcorp (TSX: G, NYSE: GG)will present as the keynote mining stock at online mining conference, Follow the Money in Mining and Metals, May 25 th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
Mining Stocks:
Goldcorp (TSX: G, NYSE: GG)
Goldcorp is the fastest growing, lowest-cost senior gold producer with operations and development projects in politically stable jurisdictions throughout the Americas. Our strong project pipeline is positioned to drive long-term, sustainable growth. A Canadian company headquartered in Vancouver, British Columbia, Goldcorp employs more than 11,500 people worldwide. Goldcorp is committed to responsible mining practices and is well-positioned to deliver sustained, industry leading growth and performance. We endeavor to deliver sustainable prosperity for our shareholders, employees, business partners and the communities in which we operate.
Contact
Jeff Wilhoit

VP, Investor Relations
(604) 696-3074
info@goldcorp.com
www.goldcorp.com Trueclaim Exploration Inc. (OTCQX: TRMNF) (TSX-V: TRM)
Trueclaim Exploration Inc. is a mineral exploration company. Trueclaim is engaged in the acquisition and development of precious and base metals properties in strategically located areas, currently within Ontario and Arizona.The Company's current principal project is the former Scadding Gold Mine near Sudbury, Ontario. The Scadding claims are part of approximately 45,000 acres the Company has assembled in this area.
Contact
Jim Elbert
jelbert@trueclaim.ca
www.trueclaimexploration.com
Running Fox (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)
Running Fox is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
Contact
Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB)
Yale Resources Yale Resources Ltd. is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months.
Contact
Ian Foreman
info@yaleresources.com
www.yaleresources.com
Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF)
Currie Rose Resources Inc. is a gold exploration company listed on the Toronto Venture Exchange under the symbol CUI-V, Frankfurt Exchange CDV, and U.S. OTC Market symbol CUIRF. The main focus is the Company's gold exploration projects in The Lake Victoria Gold Fields in Tanzania
IR contact
Harold Smith
harold@currierose.com
www.currierose.com
Strategic Resources (TSXV: UVR)
Strategic Resources is a Canadian based junior exploration company with uranium/vanadium exploration projects in Catron County, New Mexico, Rare Earth exploration projects in Lincoln County and Socorro County, New Mexico and a Lithium project in Malheur County, Oregon.
www.strategicresourcesinc.ca
IR Contact
Malcolm Bucholtz
Supercyclereport@gmail.com
Media sponsors include the Streetwise Reports / Gold Report, mining investor sites Mine Snooper www.minesnooper.com , International Mining Research Inc (www.internationalminingresearch.com ) and the investor research magazine, the Opportunist.
About www.InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.
About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations
Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: YLL is also a featured showcase stock on Investorideas.com
Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source - Investorideas.com, SmallCapVoice.com